| Bioactivity | Mosapramine (Clospipramine) is an orally active and potent dopamine receptor antagonist with high affinity to dopamine receptor subtypes 2, 3 and 4, and with moderate affinity for the 5-HT2 receptor. Mosapramine shows antipsychotic activity and can be used in schizophrenia research[1][2]. |
| Name | Mosapramine |
| CAS | 89419-40-9 |
| Formula | C28H35ClN4O |
| Molar Mass | 479.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Takahashi N, et al. Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. Neuropsychobiology. 1999;39(2):81-5. [2]. Jun Ishigooka, et al. Pilot study of plasma concentrations of mosapramine, a new iminodibenzyl antipsychotic agent, after multiple oral administration in schizophrenic patients. Current Therapeutic Research, Volume 55, Issue 3, March 1994, Pages 331-342. |
Mosapramine
CAS: 89419-40-9 F: C28H35ClN4O W: 479.06
Mosapramine (Clospipramine) is an orally active and potent dopamine receptor antagonist with high affinity to dopamine r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.